低危肾细胞癌:保留肾单位手术与根治性肾切除术后随访策略是否应不同?
基于RECUR多中心回顾数据库,研究纳入1995例pT1低危肾细胞癌患者,其中52.9%接受保留肾单位手术(PN)。多因素分析显示肿瘤大小、核分级、坏死、血管侵犯和切缘阳性与无复发生发生存(RFS)相关,而手术方式本身并非独立预后因素;PN后复发患者的癌症特异性生存优于RN后复发者,提示随访方案不应仅依赖分期和手术类型。
要点
- 手术方式(PN vs RN)不是pT1肾癌RFS或CSM的独立预后因素。
- 肿瘤大小、核分级、坏死、血管侵犯和切缘阳性与更差RFS独立相关。
- pT1肾癌根治性肾切除术后应考虑超过3年的随访。
核心结论
- 随访方案不应仅依据分期和原发手术类型,而应纳入已验证的风险因素来优化影像学选择并避免不必要检查。
- pT1肿瘤行根治性肾切除术后应考虑超过3年的随访。
研究设计与样本
- 从数据库中识别1995例低危患者(pT1、pN0、pNx),其中1055例(52.9%)接受保留肾单位手术(PN)。
主要发现
- 多因素分析中与更差无复发生存(RFS)相关的因素包括肿瘤大小(HR 1.32,95%CI 1.14-1.39;P<0.001)。
- 核分级(HR 2.31,95%CI 1.73-3.08;P<0.001)、肿瘤坏死(HR 1.5,95%CI 1.03-2.3;P=0.037)与更差RFS相关。
- 血管侵犯(HR 2.4,95%CI 1.3-4.4;P=0.005)和切缘阳性(HR 4.4,95%CI 2.3-8.5;P<0.001)与更差RFS相关。
- Kaplan-Meier分析显示PN后复发患者的癌症特异性死亡(CSM)生存显著优于RN后复发患者(P=0.02)。
- 手术类型本身并非RFS或CSM的独立预后变量。
关键数值与推荐
- 低危定义:pT1、pN0或pNx的非转移性肾细胞癌。
- pT1肿瘤行根治性肾切除术后应考虑超过3年的随访。
- 随访优化方案应纳入已验证风险因素而非仅手术类型。
临床怎么用
- 对pT1低危肾细胞癌患者,随访策略应结合肿瘤大小、核分级、坏死、血管侵犯和切缘状态等风险因素制定。
- 不应仅根据PN或RN的手术类型决定随访影像学方案。
- 根治性肾切除术后pT1患者应关注超过3年的随访。
局限性
- 研究为回顾性设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether pT1 renal cell carcinoma (RCC) should be followed differently after partial (PN) or radical nephrectomy (RN) based on a retrospective analysis of a multicentre database (RECUR). SUBJECTS: A retrospective study was conducted in 3380 patients treated for nonmetastatic RCC between January 2006 and December 2011 across 15 centres from 10 countries, as part of the RECUR database project. For patients with pT1 clear-cell RCC, patterns of recurrence were compared between RN and PN according to recurrence site. Univariate and multivariate models were used to evaluate the association between surgical approach and recurrence-free survival (RFS) and cancer-specific mortality (CSM). RESULTS: From the database 1995 patients were identified as low-risk patients (pT1, pN0, pNx), of whom 1055 (52.9%) underwent PN. On multivariate analysis, features associated with worse RFS included tumour size (hazard ratio [HR] 1.32, 95% confidence interval [CI] 1.14-1.39; P < 0.001), nuclear grade (HR 2.31, 95% CI 1.73-3.08; P < 0.001), tumour necrosis (HR 1.5, 95% CI 1.03-2.3; P = 0.037), vascular invasion (HR 2.4, 95% CI 1.3-4.4; P = 0.005) and positive surgical margins (HR 4.4, 95% CI 2.3-8.5; P < 0.001). Kaplan-Meier analysis of CSM revealed that the survival of patients with recurrence after PN was significantly better than those with recurrence after RN (P = 0.02). While the above-mentioned risk factors were associated with prognosis, type of surgery alone was not an independent prognostic variable for RFS nor CSM. Limitations include the retrospective nature of the study. CONCLUSION: Our results showed that follow-up protocols should not rely solely on stage and type of primary surgery. An optimized regimen should also include validated risk factors rather than type of surgery alone to select the best imaging method and to avoid unnecessary imaging. A follow-up of more than 3 years should be considered in patients with pT1 tumours after RN. A novel follow-up strategy is proposed.
引用
- Abu-Ghanem Y, Powles T, Capitanio U, et al. Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy? BJU Int. 2021. PMID: 33794055. doi:10.1111/bju.15415
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。